Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Distinct contributions of two subpopulations of subthalamic neurons to levodopa-induced dyskinesia.

Created on 04 Jul 2026

Authors

Bo Shen, Linlin Han, Yan Xiao, Cong Shen, Ziwei Le, Bin Wu, Lu Su, Wenbo Yu, Yimin Sun, Fengtao Liu, Haishan Yao, Jianjun Wu, Jian Wang

Published in

Science advances. Volume 12. Issue 27. Pages eaed2912. Jul 03, 2026. Epub Jul 03, 2026.

Abstract

The subthalamic nucleus (STN) is a prominent target for deep-brain stimulation (DBS) in the treatment of levodopa-induced dyskinesia (LID), a common motor complication of Parkinson's disease. However, the precise impact of STN-DBS on LID remains unclear. Here, we investigated the functional roles of two distinct neuronal populations within the STN in regulating LID. In a mouse model of LID, STN neurons projecting to the entopeduncular nucleus (EP) exhibited a U-shaped activation pattern, whereas those projecting to the tegmental reticular nucleus (RtTg) displayed a predominantly inhibitory response. Activation of EP-projecting STN neurons alleviated dyskinesia but worsened hypokinesia in the parkinsonian state. Activation of RtTg-projecting STN neurons alone did not induce hyperkinetic characteristics, except when combined with levodopa. These findings reveal two anatomically and functionally distinct populations of STN neurons involved in LID regulation, offering insights into the circuitry underlying STN-DBS.

PMID:
42397913
Bibliographic data and abstract were imported from PubMed on 04 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement